Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor

Tai‐Han Lin, Cheng‐Ping Yu, Guo‐Shiou Liao et al.|Cancers|2021

Cited by 6